# GnRH Agonist for Luteal Phase Support.

> **NCT05484193** · NA · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 150 (actual)

## Conditions studied

- Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles

## Interventions

- **DRUG:** GnRH agonist
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT05484193
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-08
- **Primary completion:** 2022-04-15
- **Final completion:** 2023-01-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05484193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05484193, "GnRH Agonist for Luteal Phase Support.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05484193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*